Excellent outcome of children/adolescents with primary mediastinal large B-cell lymphoma treated with a FAB/ LMB-based chemotherapy regimen with rituximab

Haematologica. 2024 Nov 1;109(11):3790-3794. doi: 10.3324/haematol.2024.285403.
No abstract available